Related Experiment Video
Updated: Mar 28, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
Enhancing specificity in the Janus kinases: a study on the thienopyridine JAK2 selective mechanism combined molecular
Jiao Jiao Li1, Peng Cheng1, Jing Tu1
1College of Chemistry & Chemical Engineering, Lanzhou University, Lanzhou, 730000, P. R. China. zhaihl@163.com.
Abstract:
The selective inhibition for JAK2 over the other JAK family kinases (JAK1, JAK3 and TYK2) has shared an immense challenge due to high conservatism. In this paper, the highly JAK2 selective mechanism of the thienopyridine derivative was identified at the molecular level, based on insights into the inhibitory effects of compound on four JAK kinases by molecular docking, molecular dynamic simulations, free energy calculation and decomposition. The results clearly indicated that the nonpolar contribution and the H-bond network in the hinge region played a critical selective role in stabilizing ligand JAK2, and the residues Glu930, Leu932 and Gly935 in JAK2 kinase were the key differences compared to the equivalence residues of JAK1, JAK3 and TYK2, which were further verified by simulating four complexes of JAK kinases with another highly selective thienopyridine JAK2 inhibitor . Finally, several novel molecules were designed according to above findings and further verified by the same comprehensive modeling protocol. The obtained results not only demonstrated the rationality of our models and analyses, but also suggested that the designed molecules with higher JAK2 selectivity and bioactivity potential would provide an update of JAK2 inhibitors.
Related Concept Videos
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

